Medical research and development contract DHA sbir sequential PH II proposal no. H2S-0011 titled investigation of a potassium adsorber for the treatment of hyperkalemia induced by traumatic injury and…
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH21C0045
- Awardee
-
Cytosorbents Medical Inc. UEI LSF2KFUSY4K7 Part of Cytosorbents Corporation
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,499,987
Award facts
- Contract value 100% obligated
- $1,499,987.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Medical Command Department of the Army, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 6 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Monmouth Junction, South Brunswick Township, NJ 08852, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,499,987 |
About this award
This is a $1,499,987.16 Firm Fixed Price Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer, under the Small Business Innovation Research (SBIR) program. The contract is for medical research and development to investigate a potassium adsorber for treating hyperkalemia resulting from traumatic injury and acute kidney injury in austere environments. This is a Phase II SBIR action with a completion date of February 20, 2025. The contract is set aside for small businesses.
Description
Medical research and development contract DHA sbir sequential PH II proposal no. H2S-0011 titled investigation of a potassium adsorber for the treatment of hyperkalemia induced by traumatic injury and acute kidney injury in austere medicine.
Quick answers
Who was awarded contract W81XWH21C0045?
W81XWH21C0045 was awarded to Cytosorbents Medical Inc. by Defense Health Agency (Department of Defense) on April 21, 2021.
How much is contract W81XWH21C0045 worth?
The government has obligated $1,499,987 on W81XWH21C0045.
Which agency awarded contract W81XWH21C0045?
Defense Health Agency (Department of Defense) awarded W81XWH21C0045, with funding from Medical Command (Department of the Army).
Was contract W81XWH21C0045 competed?
The extent of competition for W81XWH21C0045 was full and open competition after exclusion of sources. The government received 6 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award